Form 4: XOMA Royalty Corp Director Joseph M. Limber Reports Stock Purchases

Director Joseph M. Limber reports purchasing Depositary Shares and Preferred Stock in XOMA Royalty Corp.

Summary

• Joseph M. Limber, a director of XOMA Royalty Corp, filed a Form 4 detailing changes in beneficial ownership.
• On April 3, 2025, Limber purchased 16,524 Depositary Shares at a weighted average price of $25.22 and 1,411 shares of 8.625% Series A Cumulative Perpetual Preferred Stock at $25.44.
• On April 4, 2025, he acquired 3,476 Depositary Shares at a weighted average price of $25.25 and 3,346 shares of 8.625% Series A Cumulative Perpetual Preferred Stock at $25.56.
• On April 7, 2025, Limber purchased 5,243 shares of 8.625% Series A Cumulative Perpetual Preferred Stock at $25.6.
• Following these transactions, Limber directly owns 10,000 shares of 8.625% Series A Cumulative Perpetual Preferred Stock and 20,000 Depositary Shares, and 6,208 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the document is simply a report of transactions without additional context.

Positives

• The director's purchase of shares could be seen as a positive signal to the market, indicating confidence in the company's prospects.
• Increased insider ownership aligns management's interests with those of other shareholders.

Industry Context

Insider buying is often monitored by investors as an indicator of a company's health and future prospects within the biotechnology royalty sector.

Comparison to Industry Standards

• Comparing insider trading activity at XOMA to similar royalty companies like Ligand Pharmaceuticals or Royalty Pharma could provide context on the significance of these transactions.
• Analyzing the volume and frequency of insider buys relative to industry averages can help determine if this is a typical occurrence or a noteworthy event.

Stakeholder Impact

• The purchases may increase investor confidence.
• The purchases may have a positive impact on shareholder value.

Key Dates

Keywords

XOMA Royalty Corp, insider trading, Form 4, beneficial ownership, Joseph M. Limber, stock purchase, Depositary Shares, Preferred Stock